These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 2427475)

  • 21. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
    Zarzour SJ; Gabert HA; Diket AL; St Amant M; Miller JM
    J Matern Fetal Med; 1998; 7(6):304-7. PubMed ID: 9848697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
    Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
    J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of accurate gestational age estimation in screening for fetal neural tube defects using maternal serum alpha-fetoprotein levels.
    Kirkpatrick A; Cohen M; Prescott GH; Jones OW; Matson M; Wepsic HT
    UCLA Forum Med Sci; 1978; 20():199-205. PubMed ID: 80862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Maternal serum screening for Down syndrome and neural tube defects].
    van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH
    Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined ultrasonography and amniocentesis for pregnant women with elevated serum alpha-fetoprotein. Revising the risk estimate.
    Schell DL; Drugan A; Brindley BA; Zador IE; Johnson MP; Schwartz DB; Evans MI
    J Reprod Med; 1990 May; 35(5):543-6. PubMed ID: 1693689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
    Henriques CU; Damm P; Tabor A; Pedersen JF; Mølsted-Pedersen L
    Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effectiveness of prenatal serum biomarker screening for neural tube defects in second trimester pregnant women: a meta-analysis.
    Wang ZP; Li H; Hao LZ; Zhao ZT
    Prenat Diagn; 2009 Oct; 29(10):960-5. PubMed ID: 19609892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal serum alpha fetoprotein among pregnant females in Alexandria.
    Baghagho EE; Kharboush IF; El-Kaffash DM; KarKour TA; Ismail SR; Mortada MM
    J Egypt Public Health Assoc; 2004; 79(1-2):59-81. PubMed ID: 16916050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. When does mass screening for open neural tube defects in low-risk pregnancies result in cost savings?
    Tosi LL; Detsky AS; Roye DP; Morden ML
    CMAJ; 1987 Feb; 136(3):255-65. PubMed ID: 2433011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease.
    Heinonen S; Ryynänen M; Kirkinen P; Penttilä I; Syrjänen K; Seppälä M; Saarikoski S
    Prenat Diagn; 1996 Mar; 16(3):207-13. PubMed ID: 8710773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal serum alpha-fetoprotein screening: benefits, risks, and costs.
    Campbell TL
    J Fam Pract; 1987 Nov; 25(5):461-7. PubMed ID: 2445897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. False-positive acetylcholinesterase with early amniocentesis.
    Burton BK; Nelson LH; Pettenati MJ
    Obstet Gynecol; 1989 Oct; 74(4):607-10. PubMed ID: 2797638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal diagnosis of open neural tube defects using the amniotic fluid acetylcholinesterase assay.
    Milunsky A; Sapirstein VS
    Obstet Gynecol; 1982 Jan; 59(1):1-5. PubMed ID: 6176922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women.
    Milunsky A; Alpert E; Kitzmiller JL; Younger MD; Neff RK
    Am J Obstet Gynecol; 1982 Apr; 142(8):1030-2. PubMed ID: 6176126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of MSAFP screening on genetic services, 1984-1986.
    Greenberg F
    Am J Med Genet; 1988 Sep; 31(1):223-30. PubMed ID: 2464932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A normal ultrasound does not obviate the need for amniocentesis in patients with elevated serum alpha-fetoprotein.
    Drugan A; Zador IE; Syner FN; Sokol RJ; Sacks AJ; Evans MI
    Obstet Gynecol; 1988 Oct; 72(4):627-30. PubMed ID: 2458560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic ultrasound: early detection of fetal neural tube defects.
    Robinson HP; Hood VD; Adam AH; Gibson AA; Ferguson-Smith MA
    Obstet Gynecol; 1980 Dec; 56(6):705-10. PubMed ID: 6160439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.